Fifty percent of patients with MODY5 have a whole gene deletion of HNF1B which is associated with severe pathology, elevated HbA1c, hyperglycemia, and decreased insulin secretion with progressive pancreatic β cell dysfunction (Table 2) [12,30,134]. This evidence concerns the gene HNF1B and Hyperglycemia.